Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity

Anna Bal-Price, Pamela J Lein, Kimberly P. Keil, Sunjay Sethi, Timothy Shafer, Marta Barenys, Ellen Fritsche, Magdalini Sachana, M. E Bette Meek

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in regulatory toxicology testing and risk assessment. This concept is similar to the Mode of Action (MOA), in that it describes a sequence of measurable key events triggered by a molecular initiating event in which a stressor interacts with a biological target. The resulting cascade of key events includes molecular, cellular, structural and functional changes in biological systems, resulting in a measurable adverse outcome. Thereby, an AOP ideally provides information relevant to chemical structure-activity relationships as a basis for predicting effects of structurally similar compounds. AOPs could potentially also form the basis for qualitative and quantitative predictive modeling of the human adverse outcome resulting from molecular initiating or other key events for which higher-throughput testing methods are available or can be developed.A variety of cellular and molecular processes are known to be critical for normal function of the central (CNS) and peripheral nervous systems (PNS). Because of the biological and functional complexity of the CNS and PNS, it has been challenging to establish causative links and quantitative relationships between key events that comprise the pathways leading from chemical exposure to an adverse outcome in the nervous system. Following introduction of the principles of MOA and AOPs, examples of potential or putative adverse outcome pathways specific for developmental or adult neurotoxicity are summarized and aspects of their assessment considered. Their possible application in developing mechanistically informed Integrated Approaches to Testing and Assessment (IATA) is also discussed.

Original languageEnglish (US)
JournalNeuroToxicology
DOIs
StateAccepted/In press - Jan 26 2016

Fingerprint

Peripheral Nervous System
Neurology
Testing
Structure-Activity Relationship
Toxicology
Nervous System
Central Nervous System
Biological systems
Risk assessment
Throughput

Keywords

  • Adverse outcome pathways
  • Mode of action
  • Neurotoxicity
  • Risk assessment

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. / Bal-Price, Anna; Lein, Pamela J; Keil, Kimberly P.; Sethi, Sunjay; Shafer, Timothy; Barenys, Marta; Fritsche, Ellen; Sachana, Magdalini; Meek, M. E Bette.

In: NeuroToxicology, 26.01.2016.

Research output: Contribution to journalArticle

Bal-Price, Anna ; Lein, Pamela J ; Keil, Kimberly P. ; Sethi, Sunjay ; Shafer, Timothy ; Barenys, Marta ; Fritsche, Ellen ; Sachana, Magdalini ; Meek, M. E Bette. / Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. In: NeuroToxicology. 2016.
@article{38b0953954544f879023c06830adc229,
title = "Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity",
abstract = "The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in regulatory toxicology testing and risk assessment. This concept is similar to the Mode of Action (MOA), in that it describes a sequence of measurable key events triggered by a molecular initiating event in which a stressor interacts with a biological target. The resulting cascade of key events includes molecular, cellular, structural and functional changes in biological systems, resulting in a measurable adverse outcome. Thereby, an AOP ideally provides information relevant to chemical structure-activity relationships as a basis for predicting effects of structurally similar compounds. AOPs could potentially also form the basis for qualitative and quantitative predictive modeling of the human adverse outcome resulting from molecular initiating or other key events for which higher-throughput testing methods are available or can be developed.A variety of cellular and molecular processes are known to be critical for normal function of the central (CNS) and peripheral nervous systems (PNS). Because of the biological and functional complexity of the CNS and PNS, it has been challenging to establish causative links and quantitative relationships between key events that comprise the pathways leading from chemical exposure to an adverse outcome in the nervous system. Following introduction of the principles of MOA and AOPs, examples of potential or putative adverse outcome pathways specific for developmental or adult neurotoxicity are summarized and aspects of their assessment considered. Their possible application in developing mechanistically informed Integrated Approaches to Testing and Assessment (IATA) is also discussed.",
keywords = "Adverse outcome pathways, Mode of action, Neurotoxicity, Risk assessment",
author = "Anna Bal-Price and Lein, {Pamela J} and Keil, {Kimberly P.} and Sunjay Sethi and Timothy Shafer and Marta Barenys and Ellen Fritsche and Magdalini Sachana and Meek, {M. E Bette}",
year = "2016",
month = "1",
day = "26",
doi = "10.1016/j.neuro.2016.05.010",
language = "English (US)",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity

AU - Bal-Price, Anna

AU - Lein, Pamela J

AU - Keil, Kimberly P.

AU - Sethi, Sunjay

AU - Shafer, Timothy

AU - Barenys, Marta

AU - Fritsche, Ellen

AU - Sachana, Magdalini

AU - Meek, M. E Bette

PY - 2016/1/26

Y1 - 2016/1/26

N2 - The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in regulatory toxicology testing and risk assessment. This concept is similar to the Mode of Action (MOA), in that it describes a sequence of measurable key events triggered by a molecular initiating event in which a stressor interacts with a biological target. The resulting cascade of key events includes molecular, cellular, structural and functional changes in biological systems, resulting in a measurable adverse outcome. Thereby, an AOP ideally provides information relevant to chemical structure-activity relationships as a basis for predicting effects of structurally similar compounds. AOPs could potentially also form the basis for qualitative and quantitative predictive modeling of the human adverse outcome resulting from molecular initiating or other key events for which higher-throughput testing methods are available or can be developed.A variety of cellular and molecular processes are known to be critical for normal function of the central (CNS) and peripheral nervous systems (PNS). Because of the biological and functional complexity of the CNS and PNS, it has been challenging to establish causative links and quantitative relationships between key events that comprise the pathways leading from chemical exposure to an adverse outcome in the nervous system. Following introduction of the principles of MOA and AOPs, examples of potential or putative adverse outcome pathways specific for developmental or adult neurotoxicity are summarized and aspects of their assessment considered. Their possible application in developing mechanistically informed Integrated Approaches to Testing and Assessment (IATA) is also discussed.

AB - The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in regulatory toxicology testing and risk assessment. This concept is similar to the Mode of Action (MOA), in that it describes a sequence of measurable key events triggered by a molecular initiating event in which a stressor interacts with a biological target. The resulting cascade of key events includes molecular, cellular, structural and functional changes in biological systems, resulting in a measurable adverse outcome. Thereby, an AOP ideally provides information relevant to chemical structure-activity relationships as a basis for predicting effects of structurally similar compounds. AOPs could potentially also form the basis for qualitative and quantitative predictive modeling of the human adverse outcome resulting from molecular initiating or other key events for which higher-throughput testing methods are available or can be developed.A variety of cellular and molecular processes are known to be critical for normal function of the central (CNS) and peripheral nervous systems (PNS). Because of the biological and functional complexity of the CNS and PNS, it has been challenging to establish causative links and quantitative relationships between key events that comprise the pathways leading from chemical exposure to an adverse outcome in the nervous system. Following introduction of the principles of MOA and AOPs, examples of potential or putative adverse outcome pathways specific for developmental or adult neurotoxicity are summarized and aspects of their assessment considered. Their possible application in developing mechanistically informed Integrated Approaches to Testing and Assessment (IATA) is also discussed.

KW - Adverse outcome pathways

KW - Mode of action

KW - Neurotoxicity

KW - Risk assessment

UR - http://www.scopus.com/inward/record.url?scp=84973862422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973862422&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2016.05.010

DO - 10.1016/j.neuro.2016.05.010

M3 - Article

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

ER -